image
Healthcare - Biotechnology - NASDAQ - US
$ 6.86
-5.38 %
$ 143 M
Market Cap
-1.2
P/E
BALANCE SHEET
173 M ASSETS
-43.90%
89.5 M LIABILITIES
-29.41%
83.5 M EQUITY
-54.02%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Adverum Biotechnologies, Inc.
image
Current Assets 103 M
Cash & Short-Term Investments 96.5 M
Receivables 0
Other Current Assets 6.25 M
Non-Current Assets 70.2 M
Long-Term Investments 1.98 M
PP&E 67 M
Other Non-Current Assets 1.23 M
Current Liabilities 24.9 M
Accounts Payable 1.92 M
Short-Term Debt 20.8 M
Other Current Liabilities 2.18 M
Non-Current Liabilities 64.6 M
Long-Term Debt 64.6 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 75.0 68.4 34.2 62.4 65.9 154.9 70.5 222.2 259.1 159.4 0.6 0.4
Short Term Investments 21.5 117.2 271.0 367.3 100.1 50.1 120.0 0 37.7 0 0 0
Receivables 0 0 5.7 0 0 0 0 0.9 0.4 0 8 K 1 K
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 6.2 5.0 6.2 9.4 19.7 7.3 6.5 2.2 1.5 1.7 0.2 24 K
Total Current Assets 102.8 190.6 317.1 434.4 175.9 208.8 193.7 225.3 261.0 160.3 0.8 0.4
PP&E 67.0 113.9 119.1 47.1 45.8 3.6 3.0 4.2 3.2 1.1 69 K 4 K
Intangible Assets 0 0 0 0 0 0 5.0 5.0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 2.0 2.5 3.3 1.0 1.0 1.0 0 0 0 0 0 0
Other Long Term Assets 1.2 1.4 0.2 29 K 11 K 0.2 0.1 0.1 0.1 0.5 0.2 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 173.0 308.4 439.7 482.6 222.7 213.5 201.9 234.6 264.3 161.9 1.1 0.4
LIABILITIES
Accounts Payable 1.9 2.2 1.4 2.8 4.1 1.7 1.7 1.5 0.6 1.0 0.8 0.5
Short Term Debt 20.8 26.5 3.8 8.9 4.0 0 0 0 0 0 0 0
Other Current Liabilities 2.1 3.3 14.8 9.1 11.3 9.0 7.1 6.6 5.1 3.7 0.4 0.3
Total Current Liabilities 24.9 32.2 21.3 20.9 19.4 10.7 10.7 9.9 6.6 5.5 1.2 0.8
Long Term Debt 64.6 93.6 101.1 26.2 28.2 0.2 0 0 0 0 91 K 0.5
Deferred Tax Income 0 0 0 0 0 0 1.2 1.2 0 0 0 0
Other Liabilities 0 1.0 1.1 1.1 0.1 1.4 0.7 0.7 0.4 0.3 50 K 23 K
Total Liabilities 89.5 126.9 123.5 48.2 47.8 12.3 17.9 19.0 11.7 12.4 1.3 1.4
EQUITY
Common Stock 10 K 10 K 10 K 10 K 7 K 6 K 5 K 4 K 3 K 2 K 0 0
Retained Earnings (919.8) (802.6) (648.1) (502.5) (385.0) (320.5) (254.1) (197.9) (84.2) (36.7) (8.9) (3.6)
Other Accumulative Comprehensive Income/Loss (0.5) (1.5) (0.7) (0.3) (0.7) (0.8) (1.0) 7 K 11 K 10 K 27 K 8 K
Total Equity 83.5 181.5 316.2 434.3 175.0 201.2 184.0 215.6 252.6 149.5 (0.2) (1.0)
Total Liabilities and Equity 173.0 308.4 439.7 482.6 222.7 213.5 201.9 234.6 264.3 161.9 1.1 0.4
SHARES OUTSTANDING
Common Shares Outstanding 10.1 9.9 9.8 8.5 6.4 61.4 43.7 36.2 25.5 22.8 20.8 20.8